For States and Insurance Companies l looking at ways to prevent fraud and reimbursements for unnecessary compounded medications being Prescribed here are a few ideas

CompPharma suggests payers limit approval of compound drugs to specific situations and obtain a letter of medical necessity from a prescriber to show conventional therapy has failed. The consortium also recommends payers request proof of the effectiveness and safety of topical compounds, disapprove topical compounds with multiple ingredients, and require informed consent from patients in the absence of FDA approval.

continue to read here